The evolving field of precision medicine is very much reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care's Patient-Centered Oncology Care meeting.
The evolving field of precision medicine is really reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care’s Patient-Centered Oncology Care meeting in Baltimore, Maryland, November 13-14.
Diagnostics can define mutations and genetics of an individual tumor and allow providers to design therapeutic plans as a result.
“As drugs get developed, I think having companion diagnostics, or some connection to that field is going to be increasingly important,” he said.
Mental Health Disparities Vary by Wage Level, New Analysis Shows
April 28th 2023On this episode of Managed Care Cast, we speak with Bruce W. Sherman, MD, of Case Western Reserve University School of Medicine, about a recent study on wage-level disparities affecting the utilization of mental health resources, for which he was lead investigator; the study article appears in the April issue of The American Journal of Managed Care®.
Listen
Bridging the Gap in Health Care Inequities: Considerations in Treatment Selection, Part 2
April 6th 2023In part 2 of this 2-part series on health equity in the treatment of psoriasis, Ryan Haumschild, PharmD, and Bryan Buckley, DrPH, discuss how providers can address disparities in psoriasis care, specifically with race, cultural, and ethnic backgrounds in mind.
Listen
Dr Raj Chovatiya on Optimizing Patient-Centered Care in Atopic Dermatitis
April 24th 2023By better understanding the nature of atopic dermatitis and its varying comorbidities, providers might be able to better predict patient outcomes, said Raj Chovatiya, MD, PhD, assistant professor of dermatology, Northwestern University Feinberg School of Medicine.
Read More
TPG, AmerisourceBergen Acquire OneOncology in Deal Valued at $2.1 Billion
April 20th 2023Under the transaction, TPG, an asset management firm, will acquire a majority interest in OneOncology and AmerisourceBergen will have a minority interest; OneOncology physician leaders and practices will retain minority interests as well.
Read More
2 Clarke Drive
Cranbury, NJ 08512